In lung cancer, small molecule inhibitors targeting KRAS, EGFR, or ALK can trigger apoptosis via the mitochondrial pathway and induce pyroptosis through the caspase-3-GSDME pathway (32). This evidence concerns the gene GSDME and lung cancer.